Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions
- 6 May 2024
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 272, 116472
Abstract
No abstract availableKeywords
Funding Information
- NSTC
This publication has 266 references indexed in Scilit:
- ITGA5 promotes tumor angiogenesis in cervical cancerCancer Medicine, 2023
- An appraisal of anticancer activity with structure–activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A reviewDrug Development Research, 2022
- Multifunctional DNA Polycatenane Nanocarriers for Synergistic Targeted Therapy of Multidrug‐Resistant Human LeukemiaAdvanced Functional Materials, 2019
- A brief history of cancer: Age‐old milestones underlying our current knowledge databaseInternational Journal of Cancer, 2014
- VEGFR‐2 expression in human melanoma: Revised assessmentInternational Journal of Cancer, 2011
- Functional significance of VEGFR‐2 on ovarian cancer cellsInternational Journal of Cancer, 2008
- Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell linesCancer, 2005
- Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loopsInternational Journal of Cancer, 2003
- Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinomaCancer, 2003
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999